追蹤
Paul N. Durfee
Paul N. Durfee
University of New Mexico, Janssen R&D
在 its.jnj.com 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
CE Ashley, EC Carnes, GK Phillips, D Padilla, PN Durfee, PA Brown, ...
Nature materials 10 (5), 389-397, 2011
11952011
Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles
CE Ashley, EC Carnes, GK Phillips, PN Durfee, MD Buley, CA Lino, ...
ACS nano 5 (7), 5729-5745, 2011
3702011
Mesoporous silica nanoparticle-supported lipid bilayers (protocells) for active targeting and delivery to individual leukemia cells
PN Durfee, YS Lin, DR Dunphy, AJ Muñiz, KS Butler, KR Humphrey, ...
ACS nano 10 (9), 8325-8345, 2016
2332016
Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics
P Dogra, NL Adolphi, Z Wang, YS Lin, KS Butler, PN Durfee, JG Croissant, ...
Nature Communications 9 (1), 4551, 2018
2092018
Protocells: modular mesoporous silica nanoparticle‐supported lipid bilayers for drug delivery
KS Butler, PN Durfee, C Theron, CE Ashley, EC Carnes, CJ Brinker
small 12 (16), 2173-2185, 2016
2012016
Versatile surface functionalization of metal–organic frameworks through direct metal coordination with a phenolic lipid enables diverse applications
W Zhu, G Xiang, J Shang, J Guo, B Motevalli, P Durfee, JO Agola, ...
Advanced Functional Materials 28 (16), 1705274, 2018
1142018
Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples
SI Brett, F Lucien, C Guo, KC Williams, Y Kim, PN Durfee, CJ Brinker, ...
The Prostate 77 (13), 1335-1343, 2017
872017
Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry
CN Biggs, KM Siddiqui, AA Al-Zahrani, S Pardhan, SI Brett, QQ Guo, ...
Oncotarget 7 (8), 8839, 2016
822016
Multifunctional protocells for enhanced penetration in 3D extracellular tumoral matrices
MR Villegas, A Baeza, A Noureddine, PN Durfee, KS Butler, JO Agola, ...
Chemistry of Materials 30 (1), 112-120, 2018
642018
Understanding the connection between nanoparticle uptake and cancer treatment efficacy using mathematical modeling
TA Brocato, EN Coker, PN Durfee, YS Lin, J Townson, EF Wyckoff, ...
Scientific reports 8 (1), 1-8, 2018
572018
Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma
RS Padda, FK Deng, SI Brett, CN Biggs, PN Durfee, CJ Brinker, ...
The Prostate 79 (6), 592-603, 2019
492019
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine
Z Hunter, HD Smyth, P Durfee, B Chackerian
Vaccine 28 (2), 403-414, 2009
482009
A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells
MAG Porras, PN Durfee, AM Gregory, GC Sieck, CJ Brinker, CB Mantilla
Journal of neuroscience methods 273, 160-174, 2016
382016
Uptake and intracellular fate of cholera toxin subunit b-modified mesoporous silica nanoparticle-supported lipid bilayers (aka protocells) in motoneurons
MAG Porras, P Durfee, S Giambini, GC Sieck, CJ Brinker, CB Mantilla
Nanomedicine: Nanotechnology, Biology and Medicine 14 (3), 661-672, 2018
202018
Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955
M Bisoffi, I Klima, E Gresko, PN Durfee, WC Hines, JK Griffith, UE Studer, ...
The Journal of urology 172 (3), 1145-1150, 2004
192004
Engineering of large-pore lipid-coated mesoporous silica nanoparticles for dual cargo delivery to cancer cells
A Noureddine, EA Hjelvik, JG Croissant, PN Durfee, JO Agola, CJ Brinker
Journal of Sol-Gel Science and Technology 89, 78-90, 2019
142019
Mesoporous silica nanoparticles and supported lipid bi-layer nanoparticles for biomedical applications
CJ Brinker, PN Durfee, J Townson, YS Lin, SS Chou, J Erstling
US Patent App. 15/757,269, 2018
132018
Core and Surface Modification of Mesoporous Silica Nanoparticles to Achieve Cell Specific Targeting In Vivo.
CJ Brinker, J Townson, YS Lin, PN Durfee
US Patent App. 15/023,093, 2016
122016
Osteotropic nanoparticles for prevention or treatment of bone metastases
PN Durfee, CJ Brinker, YS Lin, H Leong
US Patent 11,672,866, 2023
42023
Active targeting of cells by monosized protocells
CJ Brinker, K Butler, PN Durfee
US Patent 11,344,629, 2022
32022
系統目前無法執行作業,請稍後再試。
文章 1–20